Abstract:Peptide amphiphiles (PAs) have been applied as building blocks for self-assembled nanostructures with various morphologies. These self-assembled nanostructures are promising drug delivery platforms as they are naturally biodegradable and biocompatible with low immunogenicity. One primary focus in drug delivery using the PA nanostructures has been to develop strongly assembled structures to avoid disassembly in the blood and allow them to carry payloads to their intended targets. In this work, rather than developing stable self-assembled PA structures, we focused on weakly assembled PA nanostructures to investigate their interactions with blood components and to understand how these interactions affect their biodistribution. We found that weakly assembled PA nanostructures (SA-E) quickly disassembled in plasma and reassembled with lipoproteins (LPs), which significantly prolonged the blood circulation of SA-E in mice. We showed that SA-E crossed the endothelial barriers through transcytosis only when they were assembled with LPs. Cellular uptake studies showed that SA-E accumulated in cancer cells through lipid-raft-mediated uptake. Interestingly, their cellular internalization was independent of LP receptors, suggesting that SA-E assembles with different endogenous biomolecules in vivo. By exploiting these endogenous interactions, SA-E demonstrated high tumor accumulation in a myriad of small animal tumor models of breast, colon, pancreatic, brain, skin, prostate, or lung cancers. SA-E demonstrated large tumor-to-background signal ratios in live animals (>5), extended retention (>2 weeks), and excellent tissue distribution (tumor to liver signal >3) in these tumor models. Encouraged by the excellent tumor accumulation of SA-E, we prepared SA-E drug conjugate using a highly potent and toxic chemotherapeutic agent, Monomethyl auristatin E (MMAE). SA-E-MMAE conjugate demonstrated strong antitumor efficacy in aggressive breast and glioma models in mice with reduced side effects. With its simple and modular design and universal tumor accumulation mechanism, SA-E represents a promising platform for broad applications in cancer therapy. Citation Format: Jared M. Fischer, Morgan Stewart, Mingchong Dai, Samuel Drennan, Sinan Sabuncu, Benjamin Kingston, Isabel Dengos, Li Xiang, Karla Bonic, Xin Yi, Srivathsan Ranganathan, Bruce Branchaud, Adem Yildirim. Peptide amphiphiles hitchhike on endogenous biomolecules for enhanced drug delivery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 487.

Self-assembling peptides induced by eyes absent enzyme to boost the efficacy of doxorubicin therapy in drug-resistant breast cancer cells

Intracellular Restructured Reduced Glutathione-Responsive Peptide Nanofibers for Synergetic Tumor Chemotherapy

Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (eisa) of Dipeptide Derivatives

In Situ Proapoptotic Peptide-Generating Rapeseed Protein-Based Nanocomplexes Synergize Chemotherapy for Cathepsin-B Overexpressing Breast Cancer.

Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells.

Enhanced Cellular Uptake and Nuclear Accumulation of Drug-Peptide Nanomedicines Prepared by Enzyme-Instructed Self-Assembly.

Enzyme-Instructed Self-Assembly Of Small D-Peptides As A Multiple-Step Process For Selectively Killing Cancer Cells

Enzyme‐Instructed Intracellular Molecular Self‐Assembly to Boost Activity of Cisplatin Against Drug‐Resistant Ovarian Cancer Cells

Self-assembly of Cytotoxic Peptide Conjugated Poly(β-Amino Ester)s for Synergistic Cancer Chemotherapy

Enzyme-instructed self-assembly of a novel histone deacetylase inhibitor with enhanced selectivity and anticancer efficiency

Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.

De novo synthesis of pH-responsive, self-assembled, and targeted polypeptide nano-micelles for enhanced delivery of doxorubicin

Selectively enhancing radiosensitivity of cancer cells via in situ enzyme-instructed peptide self-assembly

Peptide Dendrimer–Doxorubicin Conjugate‐Based Nanoparticles As an Enzyme‐Responsive Drug Delivery System for Cancer Therapy

Enzymatic Synthesis of Peptide Nanofibers for Self-Delivery of Indomethacin and Tyroservatide in Cancer Therapy

Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy

Self-assembled micelles of a multi-functional amphiphilic fusion (MFAF) peptide for targeted cancer therapy

Self-assembling Peptide-Based Nanoparticles Enhance Cellular Delivery of the Hydrophobic Anticancer Drug Ellipticine Through Caveolae-Dependent Endocytosis.

Amphiphilic Peptide Dendritic Copolymer-Doxorubicin Nanoscale Conjugate Self-Assembled to Enzyme-Responsive Anti-Cancer Agent

Enzyme-instructed Self-Assembly: a Multistep Process for Potential Cancer Therapy.

Abstract 487: Peptide amphiphiles hitchhike on endogenous biomolecules for enhanced drug delivery